ATACAND HCT (AstraZeneca Pharmaceuticals LP)
Welcome to the PulseAid listing for the ATACAND HCT drug offered from AstraZeneca Pharmaceuticals LP. This Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | AstraZeneca Pharmaceuticals LP |
| NON-PROPRIETARY NAME: | Candesartan cilexetil and Hydrochlorothiazide |
| SUBSTANCE NAME: | CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2000-09-28 |
| END MARKETING DATE: | 0000-00-00 |
ATACAND HCT HUMAN PRESCRIPTION DRUG Details:
| Item Description | ATACAND HCT from AstraZeneca Pharmaceuticals LP |
| LABELER NAME: | AstraZeneca Pharmaceuticals LP |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 16; 12.5(mg/1; mg/1) |
| START MARKETING DATE: | 2000-09-28 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0186-0162_9096d8c3-0512-4876-b940-8c72bff85a54 |
| PRODUCT NDC: | 0186-0162 |
| APPLICATION NUMBER: | NDA021093 |
Other CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE Pharmaceutical Manufacturers / Labelers:
